Omontys Approval History

• FDA approved: Yes (First approved March 27th, 2012)
• Brand name: Omontys
• Generic name: peginesatide
• Company: Affymax, Inc. and Takeda Pharmaceutical Company Limited
• Treatment for: Anemia Associated with Chronic Renal Failure

Omontys (peginesatide) an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.

FDA Approval History for Omontys

Date	Article
Mar 27, 2012	Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis
Dec  8, 2011	FDA Advisory Committee Voted in Favor of Benefit/Risk Profile for Peginesatide for Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis
Oct 24, 2011	Affymax Announces FDA Advisory Committee to Review Peginesatide
Aug 11, 2011	Affymax Announces Assignment of March 27, 2012 PDUFA Date for Peginesatide New Drug Application
Aug  5, 2011	Affymax and Takeda Announce FDA Acceptance of New Drug Application for Peginesatide
May 31, 2011	Affymax and Takeda Announce the Submission of a New Drug Application for Peginesatide for the Treatment of Anemia Associated with Chronic Renal Failure in Patients on Dialysis
Nov 29, 2010	Affymax and Takeda Confirm U.S. Registration Strategy for Investigational Drug, Hematide/peginesatide, Following Meeting with FDA

See also...

Omontys (peginesatide) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.